The amino acid sequence of human glucagon  by Thomsen, J. et al.
Volume 21, number 3 FEBS LETTERS April 1972 
THE AMINO ACID SEQUENCE OF HUMAN GLUCAGON 
J. THOMSEN, K. KRISTIANSEN, K. BRUNFELDT 
The Danish Institute of Protein Chemistry, affiliated to the Danish Academy 
of Technical Sciences, Finsensvej 33, DK-2000, Copenhagen F, Denmark 
and 
F. SUNDBY 
Novo Research Institute 
Nordre Fasenvej 215, DK-2200, Copenhagen M, Denmark 
Received 26 January 1972 
1. Introduction 
The amino acid sequence of bovine glucagon has 
been found to be the same as that reported for por- 
cine glucagon [ 1,2] . Human glucagon has been iso- 
lated and crystallized [3] . The crystal form and the 
amino acid composition of human glucagon proved 
to be identical with those of porcine and bovine 
glucagon. 
The present study reports on the amino acid se- 
quence determination of human glucagon and on 
abnormal cleavage of histidine observed during Ed- 
man degradation. 
2. Experimental 
2.1. Ghcagon 
The crystalline human glucagon was prepared by 
the method previously described for rat glucagon [3] 
and was shown by polyacrylamide electrophoresis at 
pH 4.5 and 8.7 to be homogeneous. Porcine glucagon 
(Novo Research Institute, Copenhagen, Denmark) 
was used for preliminary experiments. 
2.2. Amino acid analysis 
Amino acid analysis of the human glucagon was 
carried out after hydrolysis for 24 hr in 6 N HCl at 
110” in evacuated and sealed vials. 
2.3 Edman degradation 
The automatic Edman degradations were carried 
out in a Beckman sequencer, Model 890B. The rea- 
gents and solvents used for the sequencing were as 
follows: phenyl isothiocyanate, Quadrol-trifluoro- 
acetic acid buffer, N,N-dimethylallylamine-trifluo- 
roacetic acid buffer in pyridine/water, heptafluoro- 
butyric acid, heptane, benzene, ethyl acetate, and 
1 -chlorobutane (sequencer grade, Beckman Instru- 
ments, Palo Alto, California). N,N-dimethylallyl- 
amine (DMAA) and I-propanol (sequanal grade, 
Pierce, Rockford, Illinois). N-methylmorpholine 
(for synthesis, Merck, Darmstadt, W. Germany) was 
distilled over ninhydrin before use. 
1,4_Butanedithiol (pract. grade, Fluka, Buchs, 
Switzerland) was added without further purification 
to the 1 -chlorobutane in a concentration of 50 1.11 
per 950 ml in order to improve the yield of serine 
[4] . Before use, the Quadrol-trifluoroacetic acid 
buffer was diluted 5 .times with 1 -propanol/glass 
distilled water 3:2(v/v) in order to obtain a 0.2 M 
Quadrol buffer [5] A 1 M solution of DMAA in l- 
propanol/glass distilled water 3 :2(v/v) was used 
without pH adjustment [5] . A 1 M solution of N- 
methylmorpholine in 1 -propanol/glass distilled 
water 3:2(v/v) was also used without pH adjustment. 
2.4 Conversion and identification 
Conversions of the thiazolinones to phenylthio- 
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hydantoins (PTH) and their subsequent extraction 
were carried out a.aQr,ding to Edman and Begg [6]. 
Most of the PTI!&mim acids were identified by gas 
chromatography. For detection of PTH-arginine the 
phenanthrenequinone test [7] was used, and amino 
acid analysis after hydrolysis in 6 N HCl at 130” for 
24 hr in e\racuated and sealed vials. The identity of 
some of the other PTH-amino acids was confirmed 
by amino acid analysis. PTH-tryptophan was detec- 
ted by thin-layer chromatography in the Edman H- 
system [8] followed by spraying with Ehrlich’s rea- 
gent. The C-terminal amino acid was identified as the 
free amino acid remaining in the reaction cell by ami- 
no acid analysis without previous hydrolysis. 
2.5 Enzymatic digestion 
Digestion with carboxypeptidase-A (Sigma, St. 
Louis, Missouri) was performed in 0.2 MN-methyl- 
morpholine-acetic acid buffer, pH 8.0, at 37” for 
20 min. The enzyme/substrate ratio was approx. 
1 : 14 (mole/mole). 
2.6. Cleavage 
Cleavage with N-bromosuccinimide [9] was carried 
out after acetylation in acetic anhydride/methanol 
1:4 (v/v). 
3. Results and discussion 
3.1 Amino acid analysis 
The results of the amino acid analysis of the human 
glucagon are given in table 1. Tryptophan was des- 
troyed during the hydrolysis and appeared only in 
traces; however, typical tryptophan degradation pro- 
ducts were seen. The values for threonine and serine 
are corrected for destruction during the hydrolysis 
according to results obtained in experiments with hen 
egg-white lysozyme. The value for ammonia is correc- 
ted for the amount of ammonia present in the hydro- 
chloric acid and the buffers used. It appears that the 
amino acid composition of human glucagon is iden- 
tical with that of porcine glucagon. 
3.2. Abnormal cleavage of histidine during Edman 
degradation 
When Edman degradation of porcine glucagon was 
carried out using the volatile DMAA buffer and pro- 
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Table 1 
Amino acid analysis of human glucagon, calculated relative 
to Asp which is set to 4.0. The values in brackets are the 
nearest integer. Besides the tabulated amino acids 4.7 moles 
of ammonia, 0.15 moles of isoleucine, and traces of proline, 
cysteine and cystine were found. 
Amino acid residues per molecule 
Amino acid 
__ ._~ 
Trp 
LYS 
His 
Arg 
Asp 
Thr 
Ser 
Glu 
GlY 
Ala 
Val 
Met 
Lell 
Tyr 
Phe 
___-- 
Human Porcine 
glucagon glucagon * 
~~_~____ 
C-1 ** 1 
1.1 (1) 1 
0.9 (1) 1 
2.2 (2) 2 
4.0 (4) 4 
2.9 (3) 3 
3.7 (4) 4 
3.3 (3) 3 
1.2 (1) 1 
1.2 (1) 1 
1.2 (1) I 
0.9 (1) 1 
2.2 (2) 2 
2.0 (2) 2 
1.9 (2) 2 
* According to Bromer et al. [ 21. 
** Only traces, but typical degradation products of tryp- 
tophan. 
cedures for reducing the loss of peptide [lo] , both 
residue no.1, histidine, as well as no.2, serine, were 
found after the first degradation cycle. In the follow- 
ing cycle the remainder of residue no. 2 was found 
together with a portion of no.3, and so on, with an 
overlap of 30-50%. 
An abnormal degradation pattern of histidine has 
also been reported by Blombgck et al. [ 111 and. 
Schroeder [12] while it has not been observed by 
Edman [8]. As the two former authors used vola- 
tile buffers and the latter used the non-volatile 
Quadrol buffer, this would indicate that there is a 
relation between the abnormal degradation of the 
histidine residue and the use of a volatile buffer. 
Experiments showed that “pH” decreased to about 
6 during the drying of the DMAA buffer at the end 
of the coupling stage, and that a histidine derivative 
could be extracted from the reaction cell before 
the cleavage with heptafluorobutyric acid. After 
conversion of the derivative, PTH-histidine could 
be identified. 
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It was shown that the overlap caused by the abnor- 
mal cleavage of histidine may be reduced by an extrac- 
tion with benzene immediately after the end of the 
coupling stage, before the drying takes place, but this 
extraction will spread the film more than acceptable. 
The overlap could be completely prevented if the 
coupling was performed in a 1 M solution of N-methyl- 
morpholine in 1 -propanol/water 3 :2 (v/v) and follow- 
ed by a slight evaporation. The N-methylmorpho- 
line has a boiling point at 115-l 16”. The “pH” of 
the solution was about 9.5 and was not lower than 
9.2 during the drying. It was shown that the abnor- 
mal cleavage of histidine could also be completely 
prevented by using a 0.2 M Quadrol buffer. This re- 
sult is in agreement with the observations of Edman 
[6,8] _ It was not possible to bring about the abnor- 
mal cleavage by lowering the “pH” in the Quadrol 
buffer. This might indicate that the decrease in “pH” 
is not the only factor responsible for the abnormal 
cleavage, although experiments with volatile buffers 
seemed to indicate a certain correlation between the 
magnitude of the “pH” decrease and the abnormal 
cleavage. 
It was shown that 1.5-2 pmole of porcine glucagon 
could be degraded completely in the sequencer by 
using the 0.2 M Quadrol buffer and double cleavage 
for the first 17 degradation steps, until the second 
arginine. The DMAA buffer was used and single 
cleavage carried out for the remaining degradation 
steps. Overlap due to incomplete cleavage was there- 
by kept at a minimal level for the first 20 steps. Later 
on it was found that double cleavage, if performed 
carefully, could be used in some steps between step 
18 and 25. This strategy was used for the sequence 
determination of the human glucagon. 
3.3. Sequence determination of human glucagon 
The complete sequence of human glucagon is 
shown in fig. 1 and also the strategy used and the me- 
thods of identification. 5.1 mg of human glucagon, 
equivalent to I.5 pmole, was used for the sequencing. 
After completion of step 17 the peptide film was 
dried overnight in order to ensure better adsorption 
to the reaction cell. The program was then changed 
to the use of DMAA buffer. The film was dried over- 
night after steps 21 and 25. After step 23 the DMAA 
buffer was changed to al M DMAA solution in 1 -pro- 
panel/water because the former gave rise to extrane- 
ous peaks which interfered with the gas chromatogra- 
phic identification. In the 28th cycle the benzene 
wash was omitted. The degradation was stopped at 
the end of the 28th cycle and the C-terminal was 
identified from an aliquot of the remaining material 
in the reaction cell. 
The gas chromatographic identification failed at 
steps 22 and 28 due to interfering peaks and at step 
25 because there was no distinct peak. The phenyl- 
alanine at step 22, however, was clearly identified 
by amino acid analysis. 
The residue at step 25 which, by analogy with 
porcine glucagon, was expected to be tryptophan, 
was possibly almost destroyed during the degrada- 
tion. Thin-layer chromatography of step 25 follow- 
ed by spraying with Ehrlich’s reagent revealed a faint 
violet spot at the position of tryptophan. Additional 
information was obtained by carboxypeptidase-A 
digestion of another aliquot of the remaining mate- 
rial after the 28th degradation cycle. The sample 
residue was present in quantities indicating that 
some blocking had occurred during the degradation, 
for which reason it was expected to contain not only 
the free C-terminal amino acid but also some peptide. 
Amino acid analysis of the digest revealed the last 
5 amino acids from the C-terminal (concentrations 
in nmoles): Trp(2.0), Leu(2.1) Met(7.7) Asn/Gln 
or Ser (11.8) and Thr (12.3). The relative concen- 
trations indicate this sequence as the amino acid 
found in the highest amount is the C-terminal resi- 
due. Asn, Gln, and Ser are not separated by the tech- 
nique used. The presence of tryptophan was con- 
firmed by this experiment, which also indicated its 
position relative to the C-terminal. The final part of 
the residue from the reaction cell was cleaved by 
treatment with N-bromosuccinimide after previous 
acetylation and applied to the sequencer again. Af- 
ter the first degradation cycle, leucine was identified, 
which lends support to the finding that tryptophan 
was present at no. 25. Two more degradation cycles 
were performed but no futher residues could be 
identified. 
The identity of residue no.28 could be deduced 
from the carboxypeptidase-A experiment as being 
asparagine. The amino acid analysis of the digest 
indicated one or more residues of asparagine, gluta- 
mine, or serine. All of the serines and glutamines. 
however, had already been accounted for. The last 
317 
Volume 21, number 3 FEBS LETTERS April 1972 
1 5 JO 15 
H.His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-LeU-ASp-Ser-Arg- 
-----~----1l~----~-~ 
a a b,c 
20 25 
Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr.OH 
-r----------7 
a-a a a a 
b b b” d e 
----- 
f f 
1 --- 
a 
Fig. 1. The complete amino acid sequence of human glucagon. 
A Edman degradation, Quadrol program, double cleavage. 
- Edman degradation, DMAA program, double cleavage. 
7 Edman degradation, DMAA program, single cleavage. 
- Carboxypeptidase-A digestion. 
4 Cleavage by N-bromosuccinimide. 
a : The PTHderivative identified by gas chromatography. 
b : The PTH-derivative hydrolyzed and identified by amino acid analysis, Gln is identified as Glu. 
c : Identified by the phenanthrenequinone test. 
d : Indicated by thin-layer chromatography and Ehrlich’s reagent. 
e : The free C-terminal amino acid remaining in the reaction cell identified by amino acid analysis. 
f : Identified by amino acid analysis of the carboxypeptidase-A digest. 
of the 4 serine residues was identified at step 16 and 
consequently could not interfere. The last of the 3 
glutamine residues was found at step 24 and would 
at the most be expected to contribute to the peak of 
Asn/Gln with some 2 nmoles. Thus the remaining 
part of the peak could only be asparagine. The 3 
glutamines and 1 asparagine found, giving 4 amide 
groups, agree well with the 4.7 mole of ammonia 
shown by the amino acid analysis. 
The amino acid sequence found for human gluca- 
gon thus proved to be identical with that reported 
for porcine and bovine glucagon [ 1,2] . So far, no 
variations have been found in the amino acid sequen- 
ce of mammalian glucagons. This may indicate that 
preservation of the primary structure is essential for 
the biological activities of glucagon. The fact that the 
crystal form and the amino acid composition of rat 
and rabbit glucagon [3, 131 are found to be identical 
with those of bovine, human, and porcine glucagon 
supports this assumption. 
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